Wellfully Ltd
WFL
Company Profile
Business description
Wellfully Ltd is engaged in the research and development of Dermaportation and ETP transdermal drug delivery technologies. The company operates in segments namely the development of the dermaportation drug delivery technology and Devices segments. Geographically, it derives a majority of its revenue from Europe and also has a presence in Japan. It serves the Pharmaceutical; Cosmetics Skincare and Consumer Healthcare industries.
Contact
284 Oxford Street
Ground Floor
LeedervilleWA6007
AUST: +61 893222022
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
30 June 2026
Employees
1
Stocks News & Analysis
stocks
Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?
With the monetization of GenAI, here’s what we think of Alphabet’s stock
stocks
Going into earnings, Is Meta stock a buy, a sell, or fairly valued?
With a focus on leveraging its AI investments, here’s what we think of Meta stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,941.50 | 15.30 | 0.17% |
| CAC 40 | 7,744.41 | 53.81 | -0.69% |
| DAX 40 | 24,041.90 | 265.90 | -1.09% |
| Dow JONES (US) | 44,399.85 | 76.78 | 0.17% |
| FTSE 100 | 9,023.81 | 10.82 | 0.12% |
| HKSE | 25,130.03 | 135.89 | 0.54% |
| NASDAQ | 20,866.08 | 108.10 | -0.52% |
| Nikkei 225 | 39,774.92 | 44.19 | -0.11% |
| NZX 50 Index | 12,833.74 | 127.77 | -0.99% |
| S&P 500 | 6,299.27 | 6.33 | -0.10% |
| S&P/ASX 200 | 8,677.20 | 9.00 | 0.10% |
| SSE Composite Index | 3,581.86 | 22.07 | 0.62% |